European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours von Rinke, Anja, Ambrosini, Valentina, Dromain, Clarisse, Garcia‐Carbonero, Rocio, Haji, Amyn, Koumarianou, Anna, van Dijkum, Els Nieveen, O'Toole, Dermot, Rindi, Guido, Scoazec, Jean‐Yves, Ramage, John

Volltext

Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real‐World Data from the Spanish Tumor Registry (R‐GETNE) von Nuñez‐Valdovinos, Barbara, Carmona‐Bayonas, Alberto, Jimenez‐Fonseca, Paula, Capdevila, Jaume, Castaño‐Pascual, Ángel, Benavent, Marta, Pi Barrio, Jose Javier, Teule, Alex, Alonso, Vicente, Custodio, Ana, Marazuela, Monica, Segura, Ángel, Beguiristain, Adolfo, Llanos, Marta, Martinez del Prado, Maria Purificacion, Diaz‐Perez, Jose Angel, Castellano, Daniel, Sevilla, Isabel, Lopez, Carlos, Alonso, Teresa, Garcia‐Carbonero, Rocio

Volltext

Pembrolizumab in Asian patients with microsatellite‐instability‐high/mismatch‐repair‐deficient colorectal cancer von Yoshino, Takayuki, Andre, Thierry, Kim, Tae Won, Yong, Wei Peng, Shiu, Kai‐Keen, Jensen, Benny Vittrup, Jensen, Lars Henrik, Punt, Cornelis J. A., Smith, Denis, Garcia‐Carbonero, Rocio, Alcaide‐Garcia, Julia, Gibbs, Peter, Fouchardiere, Christelle, Rivera, Fernando, Elez, Elena, Le, Dung T., Adachi, Noriaki, Fogelman, David, Marinello, Patricia, Diaz, Luis A.

Volltext

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study von Capdevila, Jaume, Teulé, Alexandre, Barriuso, Jorge, Castellano, Daniel, Lopez, Carlos, Manzano, Jose Luis, Alonso, Vicente, García‐Carbonero, Rocío, Dotor, Emma, Matos, Ignacio, Custodio, Ana, Casanovas, Oriol, Salazar, Ramon

Volltext

ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors von Borbath, Ivan, Pape, Ulrich‐Frank, Deprez, Pierre H., Bartsch, Detlef Klaus, Caplin, Martyn, Falconi, Massimo, Garcia‐Carbonero, Rocio, Grozinsky‐Glasberg, Simona, Jensen, Robert T., Arnold, Rudolf, Ruszniewski, Philippe, Toumpanakis, C., Valle, Juan W., O´Toole, Dermot, Belli, S. H., Castaño, J. P., Chen, J, Costa, F. P., Couvelard, A, de Herder, W. W., Deroose, C. M., Dromain, C, Faggiano, A, Falkerby, J, Fazio, N, Frilling, A, Grande, E., Hand, P, Hicks, R. J., Hörsch, D, Howe, J. R., Klöppel, G, Kolarova, T, Kos‐Kudła, B, Koumarianou, A, Krejs, G. J., Krenning, E. P., Krishna, B. A., Leyden, S, Masui, T, Niederle, B, Nieveen van Dijkum, E. J., Öberg, K, Pavel, M, Perren, A, Prasad, V, Ramage, J. K., Reed, N. S., Rindi, G, Gemelli, A, Rinke, A, Rothmund, M, Singh, S., Sundin, A, Velthuysen, M. F. van, Verslype, C, Vullierme, M. P., Welin, S, Wiedenmann, B, Zhao, H

Volltext

Targeted Cancer Therapy: What's New in the Field of Neuroendocrine Neoplasms? von La Salvia, Anna, Espinosa-Olarte, Paula, Riesco-Martinez, Maria Del Carmen, Anton-Pascual, Beatriz, Garcia-Carbonero, Rocío

Volltext

The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review von Michael, Michael, Garcia‐Carbonero, Rocio, Weber, Matthias M., Lombard‐Bohas, Catherine, Toumpanakis, Christos, Hicks, Rodney J.

Volltext

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer von García‐Carbonero, Rocío, van Cutsem, Eric, Rivera, Fernando, Jassem, Jacek, Gore, Ira, Tebbutt, Niall, Braiteh, Fadi, Argiles, Guillem, Wainberg, Zev A., Funke, Roel, Anderson, Maria, McCall, Bruce, Stroh, Mark, Wakshull, Eric, Hegde, Priti, Ye, Weilan, Chen, Daniel, Chang, Ilsung, Rhee, Ina, Hurwitz, Herbert

Volltext

MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms von Soldevilla, Beatriz, Lens‐Pardo, Alberto, Espinosa‐Olarte, Paula, Carretero‐Puche, Carlos, Molina‐Pinelo, Sonia, Robles, Carlos, Benavent, Marta, Gomez‐Izquierdo, Lourdes, Fierro‐Fernández, Marta, Morales‐Burgo, Patricia, Jimenez‐Fonseca, Paula, Anton‐Pascual, Beatriz, Rodriguez‐Gil, Yolanda, Teijo‐Quintans, Ana, La Salvia, Anna, Rubio‐Cuesta, Beatriz, Riesco‐Martínez, Maria C., Garcia‐Carbonero, Rocio

Volltext

Inhibition of HSP90 molecular chaperones: moving into the clinic von Garcia-Carbonero, Rocio, MD, Carnero, Amancio, PhD, Paz-Ares, Luis, Dr

Volltext

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer von García‐Carbonero, Rocío, van Cutsem, Eric, Rivera, Fernando, Jassem, Jacek, Gore, Ira, Tebbutt, Niall, Braiteh, Fadi, Argiles, Guillem, Wainberg, Zev A., Funke, Roel, Anderson, Maria, McCall, Bruce, Stroh, Mark, Wakshull, Eric, Hegde, Priti, Ye, Weilan, Chen, Daniel, Chang, Ilsung, Rhee, Ina, Hurwitz, Herbert

Volltext

Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS- mutant advanced colorectal carcinoma von Delord, Jean-Pierre, Tabernero, Josep, García-Carbonero, Rocío, Cervantes, Andres, Gomez-Roca, Carlos, Bergé, Yann, Capdevila, Jaume, Paz-Ares, Luis, Roda, Desamparados, Delmar, Paul, Oppenheim, David, Brossard, Sophia Soehrman, Farzaneh, Farzin, Manenti, Luigi, Passioukov, Alexandre, Ott, Marion Gabriele, Soria, Jean-Charles

Volltext

Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors von Galván, Jose A, Astudillo, Aurora, Vallina, Aitana, Fonseca, Paula J, Gómez-Izquierdo, Lourdes, García-Carbonero, Rocío, González, Maria Victoria

Volltext

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizu... von Tabernero, Josep, Dr, Yoshino, Takayuki, MD, Cohn, Allen Lee, MD, Obermannova, Radka, MD, Bodoky, Gyorgy, Prof, Garcia-Carbonero, Rocio, MD, Ciuleanu, Tudor-Eliade, Prof, Portnoy, David C, MD, Van Cutsem, Eric, Prof, Grothey, Axel, MD, Prausová, Jana, MD, Garcia-Alfonso, Pilar, PhD, Yamazaki, Kentaro, MD, Clingan, Philip R, Prof, Lonardi, Sara, MD, Kim, Tae Won, Prof, Simms, Lorinda, MS, Chang, Shao-Chun, PhD, Nasroulah, Federico, MD

Volltext

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer von Mayer, Robert J, Van Cutsem, Eric, Falcone, Alfredo, Yoshino, Takayuki, Garcia-Carbonero, Rocio, Mizunuma, Nobuyuki, Yamazaki, Kentaro, Shimada, Yasuhiro, Tabernero, Josep, Komatsu, Yoshito, Sobrero, Alberto, Boucher, Eveline, Peeters, Marc, Tran, Ben, Lenz, Heinz-Josef, Zaniboni, Alberto, Hochster, Howard, Cleary, James M, Prenen, Hans, Benedetti, Fabio, Mizuguchi, Hirokazu, Makris, Lukas, Ito, Masanobu, Ohtsu, Atsushi

Volltext

VITAL phase 2 study: Upfront 5‐fluorouracil, mitomycin‐C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09‐02) von Feliu, Jaime, Garcia‐Carbonero, Rocio, Capdevila, Jaume, Guasch, Inmaculada, Alonso‐Orduna, Vicente, Lopez, Carlos, Garcia‐Alfonso, Pilar, Castanon, Carmen, Sevilla, Isabel, Cerezo, Laura, Conill, Carles, Quintana‐Angel, Begona, Sanchez, Maria E., Ghanem, Ismael, Martin‐Richard, Marta, Lopez‐Gomez, Miriam, Leon, Ana, Caro, Monica, Fernandez, Teresa, Maurel, Joan

Volltext

Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study von Van Cutsem, Eric, Martinelli, Erika, Cascinu, Stefano, Sobrero, Alberto, Banzi, Maria, Seitz, Jean‐François, Barone, Carlo, Ychou, Marc, Peeters, Marc, Brenner, Baruch, Hofheinz, Ralf Dieter, Maiello, Evaristo, André, Thierry, Spallanzani, Andrea, Garcia‐Carbonero, Rocio, Arriaga, Yull E., Verma, Udit, Grothey, Axel, Kappeler, Christian, Miriyala, Ashok, Kalmus, Joachim, Falcone, Alfredo, Zaniboni, Alberto

Volltext

Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward? von Garcia-Carbonero, Rocio, Anton-Pascual, Beatriz, Modrego, Andrea, del Carmen Riesco-Martinez, Maria, Lens-Pardo, Alberto, Carretero-Puche, Carlos, Rubio-Cuesta, Beatriz, Soldevilla, Beatriz

Volltext

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial von Pavel, Marianne, Gross, David J, Benavent, Marta, Perros, Petros, Srirajaskanthan, Raj, Warner, Richard R P, Kulke, Matthew H, Anthony, Lowell B, Kunz, Pamela L, Hörsch, Dieter, Weickert, Martin O, Lapuerta, Pablo, Jiang, Wenjun, Kassler-Taub, Kenneth, Wason, Suman, Fleming, Rosanna, Fleming, Douglas, Garcia-Carbonero, Rocio

Volltext

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer von Melisi, Davide, Oh, Do-Youn, Hollebecque, Antoine, Calvo, Emiliano, Varghese, Anna, Borazanci, Erkut, Macarulla, Teresa, Merz, Valeria, Zecchetto, Camilla, Zhao, Yumin, Gueorguieva, Ivelina, Man, Michael, Gandhi, Leena, Estrem, Shawn T, Benhadji, Karim A, Lanasa, Mark C, Avsar, Emin, Guba, Susan C, Garcia-Carbonero, Rocio

Volltext